Perfluorooctyl bromide
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
423-55-2FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)BrWTWWXOGTJWMJHI-UHFFFAOYSA-NPerflubron is a haloalkane that is perfluorooctane in which a fluorine attached to one of the terminal carbons has been replaced by a bromine. It has a role as a radioopaque medium and a blood substitute. It is a perfluorinated compound, a haloalkane and an organobromine compound. It derives from a hydride of an octane.
423-55-2DTXSID5046560CHEMBL1200866PFAS -> Other Nonpolymers
PFAS -> non-polymer
PFAS -> OECD Category
PFAS -> PFAS identified in REACH Regulation EC No. 1272/2008
PFAS -> Other/unspecified
PFAS -> Other/unspecified
Pharmaceuticals -> Various
Pharmaceuticals -> Listed in ZINC15
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H315 (90.9%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 55 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
H413: May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]
P273, and P501 (click each P-code to see the statement)
Skin Irrit. 2 (90.9%)
Hazardous to the aquatic environment (Long-term) - Category 4
V - Various
QV - Various
Perflubron emulsion (Oxygent) maintains hemodynamic stability during major surgery, thereby potentially reducing or avoiding intraoperative transfusions of donor blood in major surgery.Perflubron emulsion has ability to enable patients to be physiologically stable and safe at lower intraoperative Hb levels.
Substances used to allow enhanced visualization of tissues.
Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
Agents that increase energy expenditure and weight loss by neural and metabolic regulation.
non-polymer PFAS -> Medicinal Utensils -> Contrast agent
• Solvent for printing ink [Ref: CAS2019 (CN109810567)]
Verwenden1-BroMoheptadecafluorooctane can be used as oxygen carrier in emulsions used as blood substitutes.
CHEBI:38803